skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

70 studies were found about ( Trizivir OR abacavir AND lamivudine AND zidovudine )

Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00011895

Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00270296

Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)

Condition: HIV Infections

NCT ID: NCT00004981

Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure

Condition: HIV Infection

NCT ID: NCT00038506

Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC

Condition: HIV Infection; HIV Infections

NCT ID: NCT00865475

Tuberculosis and Human Immunodeficiency Virus (HIV) Immune Reconstitution Syndrome Trial (THIRST)

Condition: HIV; Tuberculosis

NCT ID: NCT00851630

A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV

Condition: HIV Infection

NCT ID: NCT00082394

Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients

Condition: HIV Infections

NCT ID: NCT00356616

Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR

Condition: HIV Infections

NCT ID: NCT00043888

Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults

Condition: HIV Infections

NCT ID: NCT00449436

Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects

Condition: HIV

NCT ID: NCT00960622

Safety of and Immune Response to Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults With Acute HIV Infection

Condition: HIV Infections

NCT ID: NCT00084149

FREE Study: Efficacy and Toxicity of Trizivir

Condition: HIV Infections

NCT ID: NCT00405925

Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa

Condition: Human Immunodeficiency Virus

NCT ID: NCT02028676

Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.

Condition: HIV Associated Lipodystrophy Syndrome.; HIV; Hypercholesterolemia; Lipoatrophy

NCT ID: NCT00139178

The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002389

A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults

Condition: HIV Infections

NCT ID: NCT00004585

The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs

Condition: HIV Infections

NCT ID: NCT00002391

Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00006617

Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00086359

2NN & CHARM Long-Term Follow-up Study

Condition: HIV Infections

NCT ID: NCT00127972

A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.

Condition: HIV Infections

NCT ID: NCT00002199

Study of Options for Second-Line Effective Combination Therapy (SELECT)

Condition: HIV-1 Infection

NCT ID: NCT01352715

Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01137981

A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents

Condition: HIV-1 Infection

NCT ID: NCT00915655

The Effect of Teaching HIV-Infected Patients About HIV and Treatment

Condition: HIV Infections

NCT ID: NCT00002409

A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00005764

A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00005106

A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Efficacy of TMC278 in Human Immunodeficiency Virus Infected Adolescents

Condition: Human Immuno Deficiency (HIV) Infections

NCT ID: NCT00799864

Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320

Condition: HIV Infections

NCT ID: NCT00000885

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

Condition: HIV Infections

NCT ID: NCT00013520

A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection

Condition: HIV Infections

NCT ID: NCT00002183

When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)

Condition: HIV Infections

NCT ID: NCT00234091

Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00427297

Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection

Condition: HIV Infections

NCT ID: NCT00000872

Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth

Condition: HIV Infections

NCT ID: NCT00102960

Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status

Condition: Fracture; Infection, Human Immunodeficiency Virus

NCT ID: NCT01077557

Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study

Condition: HIV Infections

NCT ID: NCT00537966

Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00428116

A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection

Condition: HIV Infections

NCT ID: NCT00000919

Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects

Condition: HIV

NCT ID: NCT00765271

Increasing HAART-Induced Immune Restoration With Cyclosporine

Condition: HIV Infections

NCT ID: NCT00031070

HIV Treatment and CVD Events

Condition: HIV Infection; Cardiovascular Disease; Infection, Human Immunodeficiency Virus; Acute Myocardial Infarction

NCT ID: NCT01054638

The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children

Condition: HIV Infections

NCT ID: NCT00000865

A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002217

Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV

Condition: HIV Infections

NCT ID: NCT00001119

A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment

Condition: HIV Infections

NCT ID: NCT00002216

Blood Levels of Abacavir in HIV Infected Adolescents

Condition: HIV Infections

NCT ID: NCT00087945

MARCH Central Nervous System Substudy

Condition: HIV-1 Infection

NCT ID: NCT01637233

Analysis of Changes in Adipose Tissue of Patients With Lipoatrophy HIV Infection Treated With Nucleoside Thymidine, After Switching to Monotherapy With Lopinavir / Ritonavir

Condition: HIV Infections

NCT ID: NCT01031849

Changing to Nonprotease Inhibitor Treatment to Improve Side Effects

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00021463

Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection With the Objective to Induce a Strong Specific HIV Immune Response Able to Control Viral Replication Without Highly Active Anti-Retroviral Therapy (HAART)

Condition: HIV

NCT ID: NCT00979706

Sex, Aging and Antiretroviral Pharmacokinetics

Condition: HIV Infections

NCT ID: NCT00666055

MARCH Renal Substudy

Condition: Proteinuria; HIV

NCT ID: NCT01637259

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Condition: HIV-Associated Lipodystrophy Syndrome; Cardiovascular Disease

NCT ID: NCT00192660

Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00078247

Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy

Condition: HIV Infection; Lipodystrophy; HIV Infections

NCT ID: NCT00865007

A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy

Condition: HIV Infections

NCT ID: NCT00102206

Clinical Trial of CNS-targeted HAART (CIT2)

Condition: HIV Infections

NCT ID: NCT00624195

A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe

Condition: AIDS-Related Kaposi's Sarcoma

NCT ID: NCT00834457

A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001086

Safety and Effectiveness of a Combination Anti-HIV Drug Treatment

Condition: HIV Infections

NCT ID: NCT00005018

Non-Interventional Observational Study With Viramune Plus Antiretroviral in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00876733

HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children

Condition: Malaria; HIV Infections

NCT ID: NCT00978068

Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children

Condition: HIV Infections

NCT ID: NCT00039741

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

Condition: HIV

NCT ID: NCT01605084

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

Condition: HIV-1 Infection

NCT ID: NCT01252940

A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment

Condition: Human Immunodeficiency Virus (HIV) Infections; Acquired Immunodeficiency Syndrome (AIDS) Virus

NCT ID: NCT01448707

Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions

Condition: Human Immunodeficiency Virus; Hepatitis B, Chronic; Hepatitis C, Chronic

NCT ID: NCT01908660

Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)

Condition: HIV Infection

NCT ID: NCT00707733